Leveraging Infrastructure Investments And Innovation To Accelerate Biologics Development

With a growing pipeline of both traditional and regenerative biopharmaceutical drugs and increasing cadence of approvals for novel biologics and biosimilars, there is a need now more than ever for readily available solutions that will translate the promise of a remarkable discovery into a successful therapy.

This webinar showcases how Thermo Fisher Scientific is leveraging infrastructure investments and innovation to deliver platform and bespoke solutions meant to accelerate biologics development.